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Background: We have previously reported that Trichinella spiralis Nudix hydrolase (TsNd) bound to intestinal
epithelial cells (IECs), and vaccination of mice with recombinant TsNd protein (rTsNd) produced a partial protective
immunity. The aim of this study was to investigate the immune protection induced by TsNd DNA vaccine.
Methods: The full-length cDNA sequence of TsNd gene was cloned into pcDNA3.1 and used to immunize BALB/c
mice by intramuscular injection. Transcription and expression of TsNd were detected by RT-PCR and IFT. The levels
of specific IgA, IgG, IgG1 and IgG2a, and cytokines were assayed by ELISA at weeks 0, 6 and 8 post-immunization.
The immune protection of TsNd DNA vaccine against challenge infection was investigated.
Results: Immunization of mice with TsNd DNA elicited a systemic Th1/Th2 immune response and a local mucosal IgA
response. The in vitro transcription and expression of TsNd gene was observed at all developmental stages of T. spiralis
(ML, IIL, AW and NBL). Anti-rTsNd IgG levels were increased after immunization and levels of IgG1 were obviously
higher than that of IgG2a. Intestinal specific IgA levels of immunized mice were significantly higher than those of
vector and PBS control mice. Cytokine profiling also showed a significant increase in Th1 (IFN-γ, IL-2) and Th2
(IL-4, 10) responses in splenocytes of immunized mice on stimulation with rTsNd. Vaccination of mice with
pcDNA3.1-TsNd displayed a 40.44% reduction in adult worms and a 53.9% reduction in larval burden.
Conclusions: TsNd DNA induced a mixed Th1/Th2 immune response and partial protection against T. spiralis
infection in mice.
Keywords: Trichinella spiralis, Nudix hydrolase (Nd), DNA vaccine, Th1/Th2Background
Trichinella spiralis is a parasitic nematode that infects
humans and other mammals [1]. Trichinellosis, caused
by the consumption of raw or undercooked meat con-
taminated with Trichinella infective muscle larvae, re-
mains an important food-borne disease with a nearly
worldwide distribution [2]. In the past several decades,
many outbreaks of human trichinellosis have been re-
ported in different areas of the world [3]. From 2004 to
2009, 15 outbreaks of human trichinellosis, with 1387
cases and 4 deaths, were reported in China [4]. The oc-
currence of trichinellosis in humans is strictly related to
cultural food practices, pork is the most important* Correspondence: cuij@zzu.edu.cn; wangzq@zzu.edu.cn
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chinellosis is not only a public health hazard but also
an economic problem in porcine animal production and
food safety [6]. Due to the predominantly zoonotic im-
portance of Trichinella infection, the development of vac-
cines capable of preventing swine from becoming infected
is a promising measure for control of trichinellosis [7-9].
T. spiralis muscle larvae (ML) are released from the
muscle tissue in the stomach by the digestive enzymes,
and activated into the intestine infective larvae (IIL) by
exposure to intestinal contents or bile. Then the IIL in-
vade host’s intestinal epithelium where the larvae de-
velop into adult worms (AW) that mate and reproduce
the next generation of larvae [10]. Therefore, the intes-
tinal mucosa is the first natural barrier in protecting the
host against Trichinella infection. In our previous study,
T. spiralis Nudix hydrolase (TsNd) protein binding tos is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Liu et al. Parasites & Vectors  (2015) 8:185 Page 2 of 10normal mouse intestinal epithelial cells (IECs) were identi-
fied by screening a T7 phage display cDNA library from T.
spiralis IIL [11]. TsNd gene (GenBank accession No.
EU263318.1) was also an up-regulated gene in IIL com-
pared to ML, which was identified by using suppression
subtractive hybridization (SSH) and confirmed by real-
time PCR [12]. The TsNd gene was about 1248 bp. The
predicted open reading frame (ORF) of TsNd encodes 415
amino acids with a molecular weight of 46 kDa and an
isoelectric point (pI) of 8.85. Conserved domain analysis
of TsNd revealed there was one Nudix motif located at
226–244 aa. The vaccination of mice with recombinant
TsNd protein (rTsNd) produced a partial protective
immunity against T. spiralis infection [13].
In recent years, many promising results and significant
protection have been reported for viral, bacterial, and
parasitic infections using the DNA heterologous prime-
boost vaccination [14-16]. In this study, to observe the
immune protection induced by TsNd DNA vaccine, the
full-length cDNA sequence of TsNd gene was cloned
into the eukaryotic expression vector pcDNA3.1 and
used to immunize BALB/c mice by intramuscular injec-
tion. In addition, the humoral and cellular immune re-
sponses elicited by the DNA vaccine were investigated.
Methods
Ethics statement
This study was carried out in strict accordance with the
National Guidelines for Experimental Animal Welfare
(MOST of People’s Republic of China, 2006). All animal
procedures reported herein were reviewed and approved
by the Zhengzhou University Animal Care and Use
Committee (Permission No. SYXK 2012–0009).
Parasite and experimental animals
The isolate (ISS534) of T. spiralis used in this study was
obtained from domestic pigs in Nanyang, Henan Province,
China. The Trichinella isolate was maintained by serial
passage in Kunming mice every 6–8 months. Specific
pathogen-free (SPF) female BALB/c mice aged 6–8 weeks
were obtained from the Laboratory Animal Center of the
Experimental Animal Center of Henan Province.
Collection of worms
T. spiralis ML from infected mice at 35 days post-
infection (dpi) were recovered by digestion of carcasses
with 0.33% pepsin (1:31000; Sigma) and 1% HCl [17].
The IIL was collected from the mouse small intestines at
6 hours post-infection (hpi). Adult worms (AW) were
isolated from the small intestines of infected mice at 7
dpi [18]. The newborn larvae (NBL) were collected from
female adult worms cultured in RPMI-1640 medium
containing 10% fetal bovine serum (FBS; Gibco) in 5%
CO2 at 37°C for 24 h [19].Plasmid construction and sequence analysis of
recombinant expression plasmids
The full-length TsNd gene (GenBank accession No.
EU263318.1) was obtained by PCR amplification using
the following primers: 5-AGGATCCGCCACCATGT
TTTACTTGGTAA CG-3 (forward), 5-ACTCGAGTTA
CCAAGTGTGTTGCAAAGCAATC-3 (reverse). The
BamHI and XhoI sites are bold and italicized. DNA en-
coding the full-length TsNd was cloned into the eukaryotic
expression vector pcDNA3.1 as DNA vaccine (pcDNA3.1-
TsNd). An artificial Kozak sequence (GCCACC) was
included in sense primers to permit efficient initiation
of translation [20]. Amplicons were ligated into the ex-
pression vector pcDNA3.1 (Invitrogen, USA) and trans-
formed into E. coli DH5a (Invitrogen). Clones containing
inserts of the expected size were selected by restriction di-
gestion and subjected to DNA sequencing using T7 and
BGH primers by Invitrogen (Invitrogen Co. Ltd, Shanghai,
China). DNA and predicted amino acid sequences were
analyzed using Lasergene 7.1 software (DNASTAR Inc.,
Madison, Wisconsin, USA). The plasmid DNA was ex-
tracted by alkaline cleavage method [16].
Expression and purification of recombinant TsNd protein
(rTsNd)
The full-length TsNd gene was cloned into the expression
vector pMAL-c2X (New England Biolabs, USA). The
rTsNd protein was expressed in E. coli under 0.5 mM
IPTG induction as described previously [13]. The rTsNd
protein was purified by Amylose Pre-packed Column
(NEB Ltd, China). The mouse anti-rTsNd serum was
collected from the mice immunized with rTsNd ob-
tained at one week after the last immunization as de-
scribed previously [21].
RT-PCR and immunofluorescent test (IFT)
The baby hamster kidney cells (BHK-21) were plated in
6-well tissue culture plates (Nunc) at 2 × 106 cells per
well in RPMI-1640 containing 5% FBS [22]. The recom-
binant pcDNA3.1-TsNd and pcDNA3.1 (1 × 108/mL)
were transfected into the BHK-21 cells with Lipofecta-
mine 2000 (Invitrogen, USA) following the manufac-
turer’s instructions. For RT-PCR assays, total RNA was
extracted from the transfected BHK-21 cells using TRI-
zol reagent (Invitrogen, USA) following the manufac-
turer’s instructions. The cDNA samples were obtained
using a cDNA First Strand Synthesis Kit (Bioer Technol-
ogy, China). Transcription of the TsNd gene in the
transfected BHK-21 cells was analyzed by RT-PCR using
specific primers listed above. For IFT, BHK-21 cells ex-
pressing TsNd proteins were cultured as monolayers and
washed with PBS and fixed with 4% acetone at room
temperature for 20 min. Then, cells were washed with
PBS and permeabilized with 1% TritonX- 100 at 4°C for
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mouse anti-rTsNd serum (1:10 dilution) at 37°C for 1 h.
After washing three times in PBS, the cells were incubated
with a 1:50 dilution of FITC-labeled goat anti-mouse IgG
(Santa Cruz, USA) in PBS at room temperature for 1 h,
after washing three times in PBS, and examined under a
fluorescent microscope (Olympus, Japan).
Immunization schedule and sample collection
BALB/c mice were randomly divided into three groups
of 40 animals each. Pre-immune sera were collected by
tail bleeding 2 days prior to the first vaccination. The
vaccine group of mice was intramuscularly injected with
TsNd-pcDNA3.1. The control group was injected with
pcDNA3.1 or PBS. The vaccination was administered
four times at 2-week intervals. For intramuscular vaccin-
ation, mice were injected with 50 μg of pure plasmid
DNA (in 50 μl of PBS) in the left and right quadriceps of
legs [15]. At weeks 0, 6 and 8 post-immunization, ten
mice from each group were euthanized; the serum, in-
testinal lavage fluid, and spleen were collected to evalu-
ate the humoral and cellular immune responses.
Evaluation of humoral immune responses by ELISA
The levels of the specific total IgG, IgG1 and IgG2a anti-
bodies to TsNd in serum samples of immunized mice
were determined by ELISA with rTsNd as described previ-
ously [23,24]. Briefly, microtiter plates (Nunc) were coated
with rTsNd (2.5 μg/ml) in coating buffer overnight at 4°C,
and blocked with 200 μl of PBS-0.1% Tween 20 (PBST)
containing 5% skimmed milk. Then, 100 μl of serum sam-
ples with 1:100 dilution in PBS were added to each well
and incubated at 37°C for 1 h. HRP-conjugated anti-
mouse IgG, IgG1 or IgG2a (1:5000; Southern Biotechnol-
ogy, USA) were added and incubated at 37°C for 1 h. The
reactions were detected by addition of the substrate o-
phenylenediamine dihydrochloride (OPD; Sigma) plus
H2O2 and stopped with 50 μl/well of 2 M H2SO4. Absorb-
ance at 490 nm was measured with a microplate reader
(TECAN, Austria). All samples were run in duplicate.
Recognition of the native TsNd in T. spiralis different
stages by IFT
The recognition of the native TsNd in T. spiralis differ-
ent developmental stages (ML, IIL, AW, and NBL) was
observed by IFT as described previously [25,26]. The in-
tact whole worms were fixed in aceton and further in-
cubated with anti-rTsNd serum from mice immunized
by TsNd DNA (1:10 dilution) at 37°C for 1 h. After be-
ing washed three times in PBS, the whole parasites
were incubated with a 1:50 dilution of FITC-labeled
goat anti-mouse IgG (Santa Cruz, USA), washed five
times in PBS, and examined under a fluorescent micro-
scope (Olympus, Japan).Measurement of total IgA and specific IgA in intestinal
washings
To determine the specific IgA, the interior of the small
intestine from immunized mice was washed twice with a
total of 1 ml of cold PBS. After centrifugation at 800 g
for 10 min, the supernatants of the intestinal washes
were harvested. The specific anti-TsNd IgA was mea-
sured by standard ELISA using an rTsNd-coated plate.
Total IgA was quantified by a sandwich ELISA using
rabbit anti-mouse IgA antibody (Abcam, UK) as the cap-
ture antibody and HRP-conjugated goat anti-mouse IgA
antibodies as the detection antibody. To compensate for
variations in the efficiency of the recovery of secretory
IgA antibodies among animals, the antigen-specific IgA
in each sample was normalized to the total IgA present
in the lavage.
Cytokine assays
To examine the specific cellular immune responses,
spleen cells were aseptically removed from immunized
and control mice at weeks 0, 6 and 8 post-immunization,
respectively [27]. The density of spleen cells obtained from
each mouse was adjusted to 2 × 106 cells/ml in complete
RPMI-1640 containing 10% fetal bovine serum (FBS),
100U/ml penicillin and 100U/ml streptomycin. Spleen
cells in 96-well plates were stimulated with the rTsNd
(2 × 1010 pfu/ml) at 37°C for 48 h in a humidified 5% CO2
atmosphere. Supernatants were collected and cytokines
(IL-2, IFN-γ, IL-4, and IL-10) were measured by ELISA
[28]. Simultaneously, the cells were incubated with ConA
as a positive control and RPMI 1640 medium alone as a
negative control. Cytokine concentrations were deter-
mined by comparison with standard curves constructed
with known amounts of the respective mouse recombin-
ant cytokines. The Results were expressed in picograms
per milliliter (pg/ml).
Challenge infection
One week after the final vaccination, the remaining 60
mice from the 3 groups (20 mice for each group) were
orally challenged with 300 T. spiralis ML. Ten mice from
each group were euthanized 7 days after challenge and
the numbers of intestinal adult worms were counted
[23]. The muscle larvae were examined by artificial di-
gestion from another 10 mice from each group 35 days
after challenge [21]. The protective immunity was calcu-
lated as the worm reduction rate of recovered adults and
larvae per gram (LPG) muscle from the immunized
groups versus those from the control group [15,29].
Statistical analysis
Data were expressed as the mean ± standard deviation.
Intra-and intergroup statistical analyses were performed
with one-way ANOVA (LSD test) using SPSS version
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significant.Results
Construction of recombinant pcDNA3.1-TsNd
The full-length cDNA encoding TsNd was cloned into
pcDNA3.1, the recombinant plasmid pcDNA3.1-TsNd
was digested with BamHI/XhoI and the results revealed
that the recombinant plasmid contained an insert of about
1248 bp (Figure 1). Sequence analysis indicated that the
amplified fragment of TsNd consisted of 1248 bp, and
the predicted ORF encoded a protein of 415 amino acid
residues with a molecular mass of 46 kDa and 99.7%
identity to the published sequence of TsNd in GenBank
(EU263318.1).The in vitro transcription and expression of TsNd gene
The in vitro transcription of TsNd gene in the BHK-21
cells was analyzed by RT-PCR. PCR products were ana-
lyzed on a 1% agarose gel with ethidiumbromide stain-
ing. The amplified TsNd fragment was observed in
pcDNA3.1-TsNd group, but the amplified fragment was
not observed in pcDNA3.1 control group (Figure 2A).
Expression of TsNd gene in BHK-21 cells was detected
by IFT. The intense green fluorescent staining using
anti-rTsNd serum was observed in BHK-21 cells trans-
fected with pcDNA3.1-TsNd, but not detected in plas-
mid pcDNA3.1 control group (Figure 2B).Figure 1 PCR identification of TsNd gene and recombinant
plasmid pcDNA3.1-TsNd digested. (A) PCR identification of TsNd
gene. M: DL2000 marker; 1: PCR product of pcDNA3.1-TsNd; (B)
Restriction endonuclease digestion of recombinant plasmid
pcDNA3.1-TsNd. M: DL2000 marker; lane 1: pcDNA3.1-TsNd; lane 2:
pcDNA3.1-TsNd digested with BamHI/XhoI; lane 3: pcDNA3.1-TsNd
digested with BamHI; lane 4: pcDNA3.1-TsNd digested with XhoI.Humoral immune responses induced by immunization
with pcDNA3.1-TsNd
The mouse sera collected at different time points after
immunization were used to measure levels of specific
anti-TsNd IgG and its subtype (IgG1 and IgG2a) anti-
bodies. Anti-TsNd IgG levels in mice immunized with
pcDNA3.1-TsNd were significantly increased following
the second and third immunization. However, none of the
mice vaccinated with pcDNA3.1 or PBS showed signifi-
cantly detectable TsNd-specific IgG antibody responses
(Figure 3A). In the immunized group with pcDNA3.1-
TsNd (Figure 3B), the levels of IgG1 on week 4 and 6 after
the first immunization were more obviously higher than
that of IgG2a (t4w = 24.756, t6w = 30.163, P < 0.01). How-
ever, it was notable that IgG2a was induced on week 4
and 6. This suggests that vaccination with pcDNA3.1-
TsNd elicited a Th1/Th2-mixed type of immune response
with Th2 predominance.
Recognition of the native TsNd at T. spiralis different
stages by IFT
The results of IFT with the whole parasites showed that
the intense fluorescent staining using anti-rTsNd serum
was found on the surface of all different developmental
stages of T. spiralis (e.g., ML, IIL at 6 hpi, AW at 3 dpi,
AW at 7 dpi and NBL). Serum from mice vaccinated
with empty plasmid pcDNA3.1 or PBS did not recognize
the T. spiralis different stages (Figure 4).
Mucosal immune response
Intestinal total IgA levels were significantly increased in
mice immunized with pcDNA3.1-TsNd compared with
those immunized with vector alone or PBS (P < 0.05). In-
testinal specific anti-TsNd IgA levels of mice immunized
with pcDNA3.1-TsNd were obviously higher than those
of immunized with vector alone or PBS (P <0.05). And
statistical difference was also observed in ratio of specific
IgA/total IgA in immunized group compared with those
vaccinated with empty plasmid pcDNA3.1 alone or PBS
(P <0.05) (Figure 5).
Cytokine responses to the immunization with pcDNA3.
1-TsNd
At week 6 after immunization, the spleen cells from mice
immunized with pcDNA3.1-TsNd produced significantly
higher levels of IFN-γ, IL-2, IL-4, and IL-10, compared
with those before immunization (P < 0.01) (Figure 6).
Moreover, the levels of four cytokines in immunized mice
continued to increase at week 8 after immunization (one
week after challenge). Compared with the empty plas-
mid pcDNA3.1 and PBS control groups, the levels of
four cytokines in immunized mice were statistically ob-
viously increased at week 6 and 8 after immunization
(P <0.01), suggesting that the vaccination of mice with
Figure 2 Transcription and expression of recombinant pcDNA3.1-TsNd in BHK-21 cells. (A) The in vitro transcription of TsNd gene in the
BHK-21 cells was analyzed by RT-PCR. PCR products were analyzed on a 1% agarose gel with ethidiumbromide staining. M: DL2000 marker; 1:
pcDNA3.1-TsNd group; 2: empty plasmid pcDNA3.1 group. (B) Expression of TsNd gene in the BHK-21 cells was detected by IFT using anti-rTsNd
serum. (a) BHK-21 cells transfected with pcDNA3.1-TsNd, (b) BHK-21 cells transfected with pcDNA3.1. The scale bar is 10 μm.
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immune response.Immune protection
To evaluate the efficacy of the recombinant DNA vac-
cine strategy, the adult worm burden and the muscle
larval burden were examined. After the challenge infec-
tion with T. spiralis muscle larvae, the mice immunized
with pcDNA3.1-TsNd displayed a statistically signifi-
cant 40.44% reduction in adult worm burden and a
53.9% reduction in muscle larvae (Figure 7), compared
with PBS control group (Fadults = 43.265, Flarvae = 14.598,
P < 0.05). The results demonstrated that the immunization
with DNA vaccine induced the partial immune protection
against challenge infection with T. spiralis larvae.Figure 3 Mouse IgG (A) and IgG subclass (B) responses to the immuniza
OD values shown for each group are the mean ± standard deviation (SD) of a
arrows (↑), and the challenge time is marked as empty arrow ( ).Discussion
In some countries (such as Mexico, Argentine, Thailand,
China, Vietnam and some Eastern European countries),
pigs are frequently raised in backyards where pigs were
often fed on raw swills [30,31], the prevalence of swine
Trichinlla infection is higher in backyards and small
farms of some countries. It is very difficult to change the
farmers’ habits of pig breeding with raw swills. Thus,
vaccines are urgently needed to prevent swine from Tri-
chinella infection. In our previous study, the rTsNd was
expressed in an E. coli expression system and the vaccin-
ation of mice with rTsNd induced a partial protective
immunity against T. spiralis infection [13]. However, the
expressed proteins in prokaryotic plasmids may differ
from the native active protein in terms of structure and
function [32].tion with pcDNA3.1-TsNd as measured by ELISA with rTsNd. The
ntibody levels (n = 10). The immunization time points are marked as solid
Figure 4 Recognition of T. spiralis different developmental stages by IFT with serum IgG from mice vaccinated with pcDNA3.1-TsNd,
empty plasmid pcDNA3.1and PBS. Scale bar =10 μm.
Liu et al. Parasites & Vectors  (2015) 8:185 Page 6 of 10
Figure 5 Anti-TsNd-specific IgA (A), total IgA (B) and specific IgA/total IgA (C) in intestinal washings of mice immunized with
pcDNA3.1-TsNd, vector or PBS. Results are the mean ± standard deviation (SD) for 10 mice per group. Asterisks (*) indicate statistically
significant differences (P < 0.05) compared to the empty plasmid pcDNA3.1 or PBS control group.
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its ability to induce a broad range of immune responses
and long lasting immunity. However, DNA vaccines re-
main poorly immunogenic compared to protein vaccines
[33]. An effective vaccine usually requires more than
one immunization in the form of a prime-boost. In
addition, the plasmid DNA is most commonly delivered
by intramuscular inoculation or via the gene gun bom-
bardment [7], but the later is practically inconvenient in
terms of cost and simplicity. It was also reported thatFigure 6 Splenocyte-secreted IFN-γ (A) IL-2 (B), IL-4 (C), and IL-10 (D)
cytokines detected in splenocyte supernatants after stimulation with the rT
concentrations ± standard deviation (SD) of 10 mice per group. *P < 0.05: in
pcDNA3.1 or PBS control group.the intramuscular route was the best one among five de-
livery routes, including oral administration [34]. In the
present study, to improve the efficacy of vaccination, the
DNA encoding the protective antigen TsNd was cloned
into the eukaryotic expression plasmid, and the recom-
binant TsNd DNA was used to immunize mice by intra-
muscular injection to induce the protective immunity
against T. spiralis infection. The results showed that a
TsNd DNA vaccine elicited a specific immune response
and partial protection against T. spiralis challenge inupon rTsNd stimulation were detected by ELISA. Concentrations of
sNd for 48 h are shown. Data are presented as the mean cytokine
dicate statistically significant differences with the empty plasmid
Figure 7 The number of intestinal adult worms (A) and larvae
per gram (LPG) of muscles (B) recovered from vaccinated mice
after a challenge infection with 300 T. spiralis larvae. Results are
presented as the arithmetic mean ± standard deviation (SD) of ten
mice each group. Asterisks (*) indicate statistically significant
differences (P < 0.05) in worm recovery of the immunized group
compared to empty plasmid pcDNA3.1 and PBS control groups.
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played a 40.44% reduction in intestinal adult worms and
a 53.9% reduction in muscle larval burden. The parasite
burden reduction observed in this study is similar with
those from the previous reports [13,15,23].
The results of RT-PCR and IFT showed that the TsNd
gene was transcribed and expressed in the BHK-21 cells,
suggesting that the recombinant plasmid pcDNA3.1-
TsNd was successfully constructed in this study. Anti-
body response analysis showed that intramuscular
immunization with TsNd DNA induced not only the
mixed systemic immune response but also the significant
local mucosal IgA secretion in mice. Previous studies
showed that secretory IgA (sIgA) played a crucial role in
mucosal defense and may limit penetration of pathogens
through the intestinal epithelium [35]. Protective im-
munity against Trichinella infection is obviously associ-
ated with the production of serological IgA [36]. IgA
provides intestinal protection in a non-inflammatory
manner. It has been demonstrated that non-specific andspecific mucosal IgA responses, as a part of the overall
immune response against the parasite, act against the in-
fective larvae and adult worms of T. spiralis in the
mouse intestine [37]. The rapid expulsion of adult
worms from the intestines might be mediated by the
sIgA against surface antigens of adult worms. Passive
transfer of anti-Trichinella IgA monoclonal antibodies to
naive mice conferred a high level of protection (more
than 95%) against Trichinella infection [38]. The intes-
tinal sIgA inhibited the in vitro fecundity of female
worms [39]. Our results showed that vaccination with
TsNd induced the production and secretion of TsNd-
specific intestinal mucosal IgA. Normally, mucosal IgA
production is strongly Th2-dependent; in particular, IL-
10 is a major cytokine that enhance IgA responses [40].
In this study, the correlation of elevated intestinal muco-
sal IgA level with high level of cytokines IL-10 upon
TsNd immunization indicates that the cytokines may
promote intestinal mucosal IgA response.
The intramuscular vaccination with pcDNA3.1-TsNd
induced specific antibody (IgG, IgA) responses, suggest-
ing the good immunogenicity of TsNd. It has been
shown that different delivery systems of vaccines influ-
ence the profile of immune responses. For example, oral
immunization with Ts87 DNA vaccine [37] elicited a bal-
anced Th1/Th2 antibody response, while subcutaneous
immunization with recombinant T. spiralis proteins in-
duced mainly Th2 antibody responses [41,42]. In this
study, the cytokines IFN-γ, IL-2, IL-4, and IL-10 secretion
by the splenocytes of mice immunized with TsNd DNA
significantly increased after immunization. In addition, the
IgG1 levels on week 4 and 6 after immunization were
more obviously higher than that of IgG2a (P <0.01), but
it was notable that IgG2a was also induced after
immunization. The results suggested that the intramus-
cular vaccination of mice with TsNd DNA vaccine in-
duced a Th1/Th2-mixed type of immune response. The
Th1/Th2-mixed type of immune responses had been
demonstrated to be important for protective immunity
against T. spiralis infection [37,43].
Since T. spiralis is an antigenically complex parasite,
the immune responses induced by single antigen vaccin-
ation may not be strong enough to combat the challen-
ging infection. The vaccination of mice with TsNd
induced a partial protective immunity against T. spiralis
infection. Hence, the polyvalent vaccine including anti-
genic epitopes from T. spiralis different stages should be
developed to improve further the efficacy of T. spiralis
vaccine [29,44,45].
Conclusions
The aim of this study was to observe the protective effi-
cacy of intramuscular immunization with the TsNd
DNA vaccine and its induced immune response. The
Liu et al. Parasites & Vectors  (2015) 8:185 Page 9 of 10results indicated that intramuscular immunization with
TsNd DNA elicited a systemic Th1/Th2-mixed type of
immune response and a strong mucosal IgA response,
and produced a partial protection against T. spiralis in-
fection in mice. However, the polyvalent vaccine includ-
ing antigenic epitopes from T. spiralis different stages
should be developed to improve further the efficacy of
T. spiralis vaccine. Additionally, the exact mechanism of
immune protection against T. spiralis infection needs to
be investigated further.
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